Immunological methods for diagnosing neurocysticercosis
US4801532A · kind A · utility
3Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 30, 1987 |
| Grant date | Jan 31, 1989 |
| Priority date | — |
| Expiry date | Sep 30, 2007 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/855
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Immunological methods are disclosed for diagnosing active human neurocysticercosis, including a serum test and a cerebrospinal fluid test. The serum test involves detecting an antibody in serum which recognizes at least one of three particular antigens isolated from Taenia solium larvae. The cerebrospinal fluid test involves detecting an antigen or antigens of larval origin, preferably by an ELISA technique.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.